TM
ADPT icon

Torren Management’s Adaptive Biotechnologies ADPT Stock Holding History

Torren Management’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.13K Hold
239
– – ﹤0.01% 333
2026
Q1 		$3.32K Sell
239
-127
-35% -$2.02K ﹤0.01% 415
2025
Q4 		$5.94K Buy
+366
New +$5.97K ﹤0.01% 878

Other funds holding ADPT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return
GIP
Granite Investment Partners El Segundo, California $1.95B AUM 49.89% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Torren Management's ADPT Position: Q2 2026 in Review

Torren Management held its Adaptive Biotechnologies (ADPT) position steady in Q2 2026 at 239 shares worth $5.13K. The position accounts for ﹤0.01% of the portfolio, ranked #333.

Torren Management first reported a position in ADPT in Q4 2025 and has held it in 3 quarters since. The position peaked at $5.94K in Q4 2025. 123 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.

  • Torren Management held 239 shares of Adaptive Biotechnologies worth $5.13K as of Q2 2026.
  • Torren Management left its Adaptive Biotechnologies share count unchanged in Q2 2026.
  • Adaptive Biotechnologies made up ﹤0.01% of Torren Management's portfolio in Q2 2026, its #333 holding.
  • Torren Management first reported a position in Adaptive Biotechnologies in Q4 2025 and has held it in 3 quarters since.
  • Torren Management's Adaptive Biotechnologies position peaked at $5.94K in Q4 2025.
  • 123 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.

Based on Torren Management's 13F filing for Q2 2026, filed 10 Jul 2026.